Beyond the Chart: Exploring the AI Frontier for Oncology

How do you know when following the guidelines is the right call… and when it isn't? That question becomes very real when you're sitting across from a patient whose situation doesn't fit neatly into the evidence. In this episode, we’re joined by Dr. Adam Bass, physician-scientist and incoming leader of the Gastroesophageal Cancer Therapeutics Accelerator at Memorial Sloan Kettering. Dr. Bass has sp...

How do you build something oncology practices will actually use and trust? In this episode, I’m joined by Lavi Kwiatkowsky, Founder and CEO of Canopy, an AI platform built specifically for the care that happens between oncology visits. Think remote patient monitoring, AI-powered call management, and the infrastructure needed to support patients when they’re not sitting in front of a clinician. Unl...

Technology in oncology is not just about efficiency or innovation. At its best, it creates more space for human connection, deeper understanding, and better care for the people behind the diagnosis. Today on Beyond the Chart, we look back at some of the most impactful conversations we’ve had on the podcast through one lens - the patient. We’re revisiting perspectives from leaders across the oncolo...

In oncology, there are 40 to 50 new drug approvals and indications every year. How is any oncologist supposed to keep up with that and still see patients? In this episode, we’re joined by the Oncology Brothers - Dr. Rohit Gosain and Dr. Rahul Gosain. Rohit is an oncologist at Roswell Park Comprehensive Cancer Center with a background in computer engineering, and Rahul practices at the Wilmot Cance...

Everyone agrees that AI will transform how we discover new cancer treatments. The big question though, is what will it take to get there? As access to new forms of data expands, the potential for breakthroughs grows with it. However, many of those breakthroughs risk never making it beyond the idea stage. This is part two of our conversation with Dr. Alicia Zhou, CEO at Cancer Research Institute. W...

What does it really take to build something new in healthcare? In this episode, I’m joined by Dr. Alicia Zhou, CEO at Cancer Research Institute. Alicia began her career as a bench scientist before moving into industry, where she spent nearly a decade as Chief Science Officer at Color, helping scale one of the Bay Area’s leading genomics companies. This is part one of our conversation, where we foc...

In oncology, much of the work happens outside the exam room. In part two of our conversation with Dr. Aparna Parikh, practicing colorectal oncologist, Program Director of GI medical oncology, and Associate Professor at Harvard Medical School, we step into the reality of what it takes to manage a complex cancer case. We talk about the preparation behind each patient visit, the coordination required...

We often talk about the workflow gaps inside oncology. But there’s an even larger gap that happens before any workflow can even begin. What if the patient never makes it to the oncologist in the first place? In this episode, I’m joined by Dr. Aparna Parikh, practicing colorectal oncologist, Program Director of GI medical oncology, and Associate Professor at Harvard Medical School. Much of Dr. Pari...

No two cancer patients follow the same path. And with modern lung cancer care being more complex than ever, the cognitive load required to reconstruct and manage each patient’s story is enormous In this episode, I’m joined by Dr. Nagashree Seetharamu, oncologist at Northwell Health and Associate Professor at the Zucker School of Medicine. Together, we explore where modern cancer care most often br...

If you think the hardest problems in cancer care are purely biological, you might change your mind after listening to this conversation. In this episode, I’m joined by Dr. Sanjay Juneja, a practicing oncologist, Vice President of Clinical AI & Informatics at Tempus, and one of the most widely followed cancer educators on social media. Dr. Juneja has built an audience of nearly one million peop...

When someone is diagnosed with cancer, care quickly begins to revolve around protocols, diagnostic pathways, treatment regimens, surveillance schedules, and clinical decisions made under enormous uncertainty. But what often gets overlooked is the life happening all around it. The fear. The relationships. The work. The identity shift. And what it actually means to live with and beyond cancer. In th...

What if rethinking the payment model in oncology is actually the fastest way to improve patient outcomes? In this episode, I’m joined by Dr. Lalan Wilfong, a practicing oncologist and Senior Vice President of Value Based Care at Thyme Care. Lalan has spent years leading value-based initiatives at Texas Oncology and the US Oncology Network, and now works at the intersection of payers, providers, an...

Change in cancer care begins when we choose to see things differently. And few people see it more clearly than Dr. Douglas Flora. Dr. Flora is a practicing oncologist, cancer survivor, Executive Medical Director at Yung Family Cancer Center, Editor in Chief of AI in Precision Oncology, President-Elect of the Association of Cancer Care Centers, and author of Rebooting Cancer Care. His lived experie...

If we were to imagine a “road to Nirvana” in oncology, what would it look like, and what will it take to build it? In this episode, we’re joined by Dr. Debra Patt, breast oncologist and Executive Vice President at Texas Oncology. She’s also president of the Community Oncology Alliance and serves on the ASCO Board of Directors, where she chairs the AI task force. There are few people in the world t...

When most people think about physician burnout, long clinic days and death by a thousand clicks comes to mind. But what if the real source of burnout is, in fact, losing time with patients? In this episode, we’re joined by Dr. Diane Reidy-Lagunes, Chief of Medical Oncology and Associate Vice President of Oncology Services at Duke University Health System.  We explore what burnout really means for...

We often hear clinicians talking about how AI is helping them deliver better care, but not enough people are asking how. In this episode, we’re joined by someone who understands both sides - Dr. Ravi  Parikh, medical oncologist and Director of the Human-Algorithm Collaboration Lab (HACLab) at Emory University and Winship Cancer Institute. We unpack what responsible AI adoption really looks like in...

Technology can actually make oncology care feel more human by restoring trust and presence between doctors and patients. In this episode, Kathy Oubre, CEO of Pontchartrain Cancer Center, shares how community oncology faces unique challenges compared to academic centers, including competition with 340B hospitals and the need for resilience and innovation. She highlights how adopting ambient AI enha...

What if ambient AI could do more than just take notes? In this episode, Dr. Sean Khozin, CEO of the CEO Roundtable on Cancer (CEORT) and its data arm Project Data Sphere (PDS), explains why rebuilding trust after the EHR era is key to adoption, how ambient AI can move beyond documentation to enhance physician intuition, and why it’s time to rethink outdated “gold standards” like RECIST. He also di...

What if your voice could become the next frontier in cancer care? In this first part of the 2-part episode, Dr. Sean Khozin, CEO of the CEO Roundtable on Cancer (CEORT) and its data arm Project Data Sphere (PDS), shares how ambient AI can restore the doctor–patient bond lost to electronic health records, why voice is a powerful digital biomarker for pain, mood, and neurological changes, and how PD...

The biggest breakthroughs in AI and oncology aren't just about speed, they're about bridging the gap between academic innovation and real-world care. In this episode, Dr. Stephen Speicher, Head of Clinical Oncology and Patient Safety at Flatiron Health, shares his journey from clinical practice to health tech leadership, driven by a mission to humanize care through technology. He explores how spec...

AI can succeed in community oncology by delivering a clear return on investment for physician-owners while also restoring the vital human connection between doctors and patients. In this episode, Larry Bilbrey, Director of Data Insights and Innovations at Tennessee Oncology and Senior Director of Digital Innovation at OneOncology, shares the complex journey of driving AI adoption across a national...

The future of cancer care lies in the combination of cutting-edge AI and compassionate, community-based treatment. In the first episode, Dr. Gury Doshi, Medical Director at Texas Oncology and Chair, P&T at US Oncology Network, highlights how technology is transforming cancer care and clinician well-being. She explains that community oncology now delivers over 70% of treatments outside academic...